Okla. Admin. Code § 310:521-3-3

Current through Vol. 42, No. 4, November 1, 2024

Section 310:521-3-3 - Standards of tuberculosis treatment

(a) The Commissioner shall establish surveillance to identify all cases of tuberculosis in Oklahoma. All tuberculosis suspects shall be investigated to establish or exclude the diagnosis of tuberculosis disease.

(b) A person with tuberculosis in a contagious state will remain in isolation until non-contagious criteria are met.

(c) The Commissioner shall:

(1) Review the Tuberculosis treatment regimen for each person with active or suspected tuberculosis,

(2) Make recommendations for change, as indicated, and

(3) Establish the anticipated length of therapy.

(d) Directly Observed Therapy (DOT) shall be the standard for treatment of persons determined to have active tuberculosis disease. Exceptions may be granted by the Commissioner when necessary and for cause.

(e) Compliance orders will be issued to tuberculosis patients to establish behavioral expectations in regard to treatment, isolation and monitoring.

(f) Tuberculosis treatment shall continue by DOT until a prescribed course of therapy has been completed.

(g) Non-compliant behavior in regard to treatment, isolation or patient monitoring will be reported to the Commissioner. Action will be taken to eliminate the non-compliant behavior when possible or to pursue enforcement action, as determined by the Commissioner.

Okla. Admin. Code § 310:521-3-3

Added at 19 Ok Reg 2075, eff 6-27-02; Amended at 25 Ok Reg 1148, eff 5-25-08